| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |